Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylation of cfDNA in Diagnosing and Monitoring Benign and Malignant Pulmonary Nodule

NCT03989219 is registered in ClinicalTrials.gov with Jiayuan Sun as lead sponsor.

NCT NCT03989219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03989219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylation of cfDNA in Diagnosing and Monitoring Benign and Malignant Pulmonary Nodule
Lead sponsor
Jiayuan Sun
Phase
Observational
Overall status
Completed
Start date
August 15, 2018
Completion date
June 30, 2022
Enrollment
401 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary nodule, solitary